Tivic Health Systems, Inc. (TIVC)
NASDAQ (CM) NASDAQ (CM) Primary Summary
TIVC Chart
Tivic Health Extends its Worldwide License of TLR5 Agonist Entolimod to Include the Treatment of Neutropenia
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, today announced that, on March 28, 2025, it exercised its licensing option for the exclusive, worldwide rights to advance Entolimod™ for a second indication, Neutropenia. This expansion of commercial rights is part of the license agreement with Statera Biopharma for its late-stage Toll-like Receptor 5 (TLR5) immunotherapy program Entolimod™. Neutropenia is a condition characterized b.
Tivic Health Systems, Inc. Regains Compliance with NASDAQ Minimum Bid Price Listing Rule
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, announced today that it has received confirmation from Nasdaq that the Company has regained compliance with the minimum bid requirements of Nasdaq Listing Rule 5550(a)(2). Consequently, Tivic Health's common stock will continue to be listed and traded on the Nasdaq Capital Market under the symbol “TIVC.” About Tivic Health Systems, Inc. Tivic Health is a diversified therapeutics com.
Tivic Health Systems, Inc. (TIVC) Q4 2024 Earnings Call Transcript
Tivic Health Systems, Inc. (NASDAQ:TIVC ) Q4 2024 Results Conference Call March 21, 2025 4:30 PM ET Company Participants Jennifer Ernst - Chief Executive Officer Lisa Wolf - Interim Chief Financial Officer Operator Welcome to Tivic Health Systems Year-End 2024 Financial Results and Operational Update Conference Call. This call has been prerecorded and the questions you have submitted in advance will be answered following prepared remarks.
Tivic Health Systems, Inc. (TIVC) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Tivic Health Systems, Inc. ever had a stock split?
Tivic Health Systems, Inc. Profile
| Medical Devices Industry | Healthcare Sector | Ms. Jennifer Ernst CEO | NASDAQ (CM) Exchange | US8887051006 ISIN |
| US Country | 9 Employees | - Last Dividend | 7 Mar 2025 Last Split | 11 Nov 2021 IPO Date |
Overview
Tivic Health Systems Inc. is a pioneering health technology company that is dedicated to the development and commercialization of non-invasive bioelectronic medicine. Founded in 2016 and based in Hayward, California, Tivic Health Systems Inc. is at the forefront of innovative treatments focusing on the well-being of its customers. The company leverages advanced technology to provide solutions that address common health concerns in a novel, safe, and effective manner. Its operations span direct-to-consumer sales through its own website and well-known online marketplaces, ensuring accessibility and convenience for consumers across the United States.
Products and Services
- ClearUP
ClearUP is Tivic Health Systems Inc.'s flagship product, which epitomizes the company's commitment to bioelectronic medicine. This innovative device is specifically designed for the treatment of sinus and nasal congestion pain. It is a testament to the company's pioneering spirit, harnessing the power of bioelectronics to offer a non-invasive, drug-free alternative for individuals suffering from these conditions. Available through the company's direct-to-consumer channels, including its website, Amazon.com, Walmart.com, and other U.S. online retailers like BestBuy and FSAStore, ClearUP aims to revolutionize the way individuals manage sinus and nasal congestion, prioritizing efficiency and user-friendliness.
Contact Information
